Are you dealing with multiple myeloma that keeps coming back or hasn't improved? If you are, you may be able to join a study to see if a new drug called ABBV-383 could be safe and helpful for people in your situation. You will be reimbursed for travel expenses. You will not have to pay for the drug while you take part in this study.

To understand the views and perceptions of Ugandan social work academics who utilize decolonial and indigenous theories and practices, including ubuntu, in their work.

In this study, we want to see how learning a second language could change how you pronounce words in your first language. This will help us understand how sounds from different languages mix in our minds.

We are conducting interviews with members of the community to understand their perceptions related to mold in the home, and to capture any behaviors and concerns they have about mold.

Have you been diagnosed with Chronic Lymphocytic Leukemia (CLL) that has transformed to aggressive lymphoma called Richter's Transformation (RT)? Then you may be able to participate in this study whose purpose is to evaluate the efficacy and safety of glofitamab as monotherapy and in combination with polatuzumab vedotin or atezolizumab for participants with Richter's Transformation (RT) that has transformed from chronic lymphocytic leukemia (CLL). These are targeted immune-based therapies standardly used to treat lymphoma and/or other cancers that may also work well for RT

The purpose of this study is to understand if a new oral medication (pill) can be used to treat depression in people who have not felt relief from other anti-depression medications.

In this study, we want to learn more about the impacts of displacement due to a natural disaster in the United States. We are looking for professionals with experience in climate change and disaster mitigation and for those displaced due to a natural disaster. Findings from this study may help us understand how state infrastructure may impact climate change resiliency.

In this study, we want to learn how people find and understand information. We want to see how this information affects their lives and their thoughts on money.

In this study, we want to improve virtual healthcare by seeking feedback from those who have used virtual care (ex. telehealth, or e-visits). We are looking for patients, administrators, providers or policymakers to provide feedback through individual, private interviews. Your perspective will help us to foster equitable and sustainable virtual care solutions.

Do you have ovarian, peritoneal, or fallopian tube cancer that came back after receiving standard therapy? If so, you might be able to take part in a study that looks at a new treatment, iC9.CAR.B7-H3 cells, to test the safety of these cells and observe any side effects.